Bringing Innovation to Life. Faster. Leaner. Better.
BKmed GmbH – Agile market development and exclusive distribution for innovative medical devices across the DACH region.
Proven Expertise. Agile Execution.
We combine the professionalism and reliability of a senior expert with over 30 years of ENT industry experience with the speed and agility of a modern launch partner. The result: medical devices reach the DACH market faster, leaner, and with the precision that only comes from deep market knowledge.
NETWORK & EXPERTISE
The ENT Expert Network
Deeply rooted in clinics and private ENT practices across Germany, Austria, and Switzerland — our network of specialists is the key USP for manufacturers of innovative medical devices.
Strategic Partnerships
Long-standing, reliable connections to international distributors and leading manufacturers — the foundation for successful DACH market entry.
Senior Business Development
Over three decades of experience in medical device distribution across Germany: market entry and the development of sustainable distribution structures.
OTINOVA®
The antibiotic-free solution for otitis externa.
The physical mechanism of action is based on an aluminium acetate–acetic acid solution that effectively stops the growth of bacteria and fungi in the ear canal — without the use of antibiotics and therefore without the risk of antibiotic resistance.
100% free of antibiotics and cortisone. Clinically documented CE medical device — an important contribution against antibiotic resistance.
Physical action through aluminium acetate–acetic acid solution: antibacterial and antifungal treatment for ear canal infections.
Targeted solution for swimmer’s ear prevention, water sports enthusiasts, and users of hearing aids and in-ear headsets.
TINEARITY G1
Advanced bone conduction therapy for tinnitus.
The system uses bone conduction technology for flexible Tinnitus Retraining Therapy (TRT). White noise is delivered directly to the inner ear via the bone while the ear canal remains completely open — a decisive advantage over conventional in-ear solutions, as normal hearing is not impaired.
The open ear canal makes use particularly comfortable and safe during sleep. Targeted masking achieves long-term habituation to the tinnitus sound.
White noise via bone conduction — the ear canal stays open for unrestricted natural hearing.
Supports Tinnitus Retraining Therapy (TRT) through continuous masking and long-term habituation.
Optimised for use during sleep. Approved medical device ensuring highest patient safety.
THE BKMED ACCELERATOR
Three steps to market success.
We believe innovative medical devices don’t need a heavy sales apparatus — they need a partner who understands the market and acts fast.
Strategic Matching
In-depth analysis and targeted network assessment for optimal product positioning in the DACH market.
Agile Market Entry
Efficient activation without bureaucratic overhead — direct, fast, and clearly structured.
Sustainable Scaling
Long-term success through the systematic development of stable distribution structures across the DACH region.
Success in medical technology is not a coincidence — it is the result of trust and well-founded market knowledge. For over 30 years, we have been bringing innovations to where they are needed most: to the patient.
MANAGING DIRECTOR
Expertise that opens doors.
Jan-Eric Bialek · BKmed GmbH
Jan-Eric Bialek combines 30 years of medical device distribution experience with the determination of a modern enabler. He doesn’t just understand the ENT market — he has helped shape it for decades. As Managing Director of BKmed GmbH, he is the strategic mind behind every DACH market entry, always focused on efficiency, reliability, and measurable success. His ENT expert network of clinics and private specialists is the decisive advantage for manufacturers of innovative medical devices.